Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Explore this paper's citation graph
Summary
There are significant favorable changes in HDL-C, total triglycerides, and VLDL-T between patients with mild to moderate hypertension and normal plasma lipids when treated with the alpha-blocker doxazosin compared with the beta-blockers atenolol.
- Type
- article
- Published
- 1994-08-01
- Cited by
- 29
- References
- 55
- Access
- Open access
- OpenAlex
- https://openalex.org/W8039850
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11366194
Keywords
Political science
References
- Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
- Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension.
- Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
- Antihypertensive treatment and serum lipoproteins.
- Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.
- Characterization and metabolic fate of two very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography.
- Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction.
- The Association of Serum Lipids, Lipoproteins, and Apolipoproteins with Coronary Artery Disease Assessed by Coronary Arteriography
- Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
- Antihypertensive Drugs and Blood Lipids: The Oslo Study
- Relation of parental history of early myocardial infarction to the level of apoprotein B in men.
- Long‐Term Double‐Blind Comparison of Doxazosin and Atenolol in Patients with Mild to Moderate Hypertension
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
- Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension
- A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
- Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
- Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
- Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
- Beta-blockers and plasma triglycerides.
Cited by
- Lipide und Kohlenhydrate unter antihypertensiver Therapie mit den b-Blockern Celiprolol und Metoprolol und dem ACE-Hemmer Benazepril – eine 4x4 cross-over Studie an Typ-2-Diabetikern
- Correlation between serum butyrylcholinesterase activity and serum lipid concentrations in rats treated with different antagonists of the adrenergic system
- Hypertensive Treatment in Patients With Metabolic Syndrome
- Effects of Acute Administration of Doxazosin on Fasting and Postprandial Haemodynamics and Lipid Metabolism in Healthy Subjects
- Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertension.
- Review: the effects of antihypertensive agents on serum lipids.
- Dyslipidemia Induced by Atenolol in Common Rabbits Oryctolagus cuniculus
- Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension
- Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.
- Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy
- Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
- Apolipoprotein E Polymorphisms and Concentration in Chronic Diseases and Drug Responses
- Effects of β-blockers on glucose and lipid metabolism
- The Impact of Carvedilol and Metoprolol on Serum Lipid Concentrations and Symptoms in Patients with Hyperthyroidism
- Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
- Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein.
- The Combination of Nebivolol plus Pravastatin is Associated with a More Beneficial Metabolic Profile Compared to that of Atenolol plus Pravastatin in Hypertensive Patients with Dyslipidemia: A Pilot Study
- A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
- The pathophysiology of perioperative myocardial infarction: facts and perspectives.
- METABOLIC AND HAEMODYNAMIC EFFECTS OF PP-28 IN FRUCTOSE-FED WISTAR RATS.
Related papers
No related papers recorded.